Patents by Inventor HIDAYTULLA AGA

HIDAYTULLA AGA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation of cefixime for enhanced bioavailability
    Patent number: 9149482
    Abstract: A chewable tablet comprising Cefixime having a mean particle size between 20? and 120? wherein the said composition demonstrates bioequivalence to a suspension of Cefixime trihydrate. The process of preparation of the chewable tablet comprises the steps of optionally micronizing Cefixime such that the mean particle size of the Cefixime particles is between 20? and 120?, blending with other excipients, roll compaction, milling to form granules, blending to form a secondary blend and compression of the secondary blend to form tablets.
    Type: Grant
    Filed: May 10, 2004
    Date of Patent: October 6, 2015
    Assignee: Lupin Ltd.
    Inventors: Sanjay Wagh, Hidaytulla Aga, Makarand Avachat, Himadri Sen
  • NOVEL PHARMACEUTICAL FORMULATION OF CEFIXIME FOR ENHANCED BIOAVAILABILITY
    Publication number: 20140171401
    Abstract: A chewable tablet comprising Cefixime having a mean particle size between 20? and 120? wherein the said composition demonstrates bioequivalence to a suspension of Cefixime trihydrate. The process of preparation of the chewable tablet comprises the steps of optionally micronizing Cefixime such that the mean particle size of the Cefixime particles is between 20? and 120?, blending with other excipients, roll compaction, milling to form granules, blending to form a secondary blend and compression of the secondary blend to form tablets.
    Type: Application
    Filed: February 24, 2014
    Publication date: June 19, 2014
    Applicant: LUPIN LTD.
    Inventors: Sanjay WAGH, Hidaytulla AGA, Makarand AVACHAT, Himadri SEN
  • EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF PALIPERIDONE
    Publication number: 20110052687
    Abstract: The present invention provides an extended release tablet of paliperidone, comprising a) a core containing paliperidone and at least one water soluble and/or gellable polymer, b) a coating comprising at least one water insoluble or permeable polymer, and a water soluble and/or gellable polymer and optionally an enteric polymer.
    Type: Application
    Filed: August 25, 2010
    Publication date: March 3, 2011
    Applicant: GLENMARK GENERICS LTD
    Inventors: Kamal Mehta, Pankaj Shinde, Hidaytulla Aga, Rajadeep Gupta
  • TABLET COMPOSITIONS OF AMINE POLYMERS
    Publication number: 20100008988
    Abstract: The present invention provides pharmaceutical compositions, essentially comprising less than about 95% by weight of an aliphatic amine polymer. The present invention relates to pharmaceutical compositions comprising aliphatic amine polymers of sevelamer hydrochloride, sevelamer carbonate and colesevelam hydrochloride; and methods of preparing pharmaceutical compositions thereof.
    Type: Application
    Filed: July 13, 2009
    Publication date: January 14, 2010
    Applicant: GLENMARK GENERICS, LTD.
    Inventors: KAMAL MEHTA, SRINIVAS GANGA ARRA, HIDAYTULLA AGA
  • PHARMACEUTICAL COMPOSITIONS COMPRISING SUMATRIPTAN AND NAPROXEN
    Publication number: 20100008986
    Abstract: The present invention relates to the pharmaceutical composition comprising sumatriptan succinate and naproxen sodium, with a proviso that both the active components are in admixture with each other.
    Type: Application
    Filed: July 13, 2009
    Publication date: January 14, 2010
    Applicant: GLENMARK GENERICS, LTD.
    Inventors: KAMAL MEHTA, HIDAYTULLA AGA, SANJAY KUMAR SAHU
  • Novel Extended Release Composition of Venlafaxine Hydrochloride Containing Polyvinyl Acetate
    Publication number: 20070292500
    Abstract: Extended release pharmaceutical composition of Venlafaxine hydrochloride comprising a pharmaceutically acceptable capsule containing minitablets. The minitablets comprise from about 20% to about 70% by weight effective amount of Venlafaxine hydrochloride, polyvinyl acetate, one or more pharmaceutically acceptable excipients. The minitablets have diameter from about 1 mm to 5 mm and are coated with a release controlling composition.
    Type: Application
    Filed: May 21, 2004
    Publication date: December 20, 2007
    Applicant: LUPIN LTD.
    Inventors: Sanjay Wagh, Hidaytulla Aga, Himadri Sen
  • Novel Pharmaceutical Formulation of Cefixime for Enhanced Bioavailability
    Publication number: 20070286901
    Abstract: A chewable tablet comprising Cefixime having a mean particle size between 20 ? and 120 ? wherein the said composition demonstrates bioequivalence to a suspension of Cefixime trihydrate. The process of preparation of the chewable tablet comprises the steps of optionally micronizing Cefixime such that the mean particle size of the Cefixime particles is between 20 ? and 120 ?, blending with other excipients, roll compaction, milling to form granules, blending to form a secondary blend and compression of the secondary blend to form tablets.
    Type: Application
    Filed: May 10, 2004
    Publication date: December 13, 2007
    Applicant: Lupin Ltd.
    Inventors: Sanjay Wagh, Hidaytulla Aga, Makarand Avachat, Himadri Sen
  • Solid Unit Dosage Forms of 5-Ht1 Agonist
    Publication number: 20070269510
    Abstract: The present invention relates to pharmaceutical compositions of 5-HT1 agonist. More particularly, the present invention relates to uncoated tablets of sumatriptan succinate. The present invention also relates to a process for the preparation of uncoated tablets of sumatriptan succinate.
    Type: Application
    Filed: September 26, 2005
    Publication date: November 22, 2007
    Inventors: Sudarshan Nimbalkar, Kishor Deo, Hidaytulla Aga, Sivakumaran Meenakshisunderam